Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
5 Jan 2026
Director
Buy indirect
7,111
$3.50
$24.89K
Ra Capital Management, L.p.
12 Dec 2025
Director
Buy indirect
101,462
$2.86
$290.18K
Ra Capital Management, L.p.
11 Dec 2025
Director
Buy indirect
213,099
$2.18
$464.56K

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 20,578,750
History held since 11 Aug 2021